Cargando…

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma

Early response evaluation with [(18)F]fluordeoxyglucose (FDG) positron emission tomography after 2 cycles of chemotherapy (interim PET) has been indicated as the strongest predictor for outcome in classical Hodgkin lymphoma (HL). We studied the prognostic role of the number of tumor‐infiltrating CD6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuccaro, Annarosa, Annunziata, Salvatore, Cupelli, Elisa, Martini, Maurizio, Calcagni, Maria L., Rufini, Vittoria, Giachelia, Manuela, Bartolomei, Francesca, Galli, Eugenio, D'Alò, Francesco, Voso, Maria T., Leone, Giuseppe, Giordano, Alessandro, Larocca, Luigi M., Hohaus, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799945/ https://www.ncbi.nlm.nih.gov/pubmed/26758564 http://dx.doi.org/10.1002/cam4.585

Ejemplares similares

Prognostic Factors in Hodgkin Lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2014)

PD‐L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2022)

Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients
por: Ferretti, Elisa, et al.
Publicado: (2017)

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
por: Hohaus, Stefan, et al.
Publicado: (2020)

Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization
por: Hohaus, Stefan, et al.
Publicado: (2018)

Primary Pancreatic Lymphoma in a Patient with Maturity Onset Diabetes of the Young Type 3
por: Bozzoli, Valentina, et al.
Publicado: (2012)

Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden
por: Leccisotti, Lucia, et al.
Publicado: (2022)

Severe CMV Infection after Chemo-Immunotherapy with Dose-Reduced Bendamustine and Rituximab in a Mantle Cell Lymphoma Old Patient
por: Magliano, Gabriele, et al.
Publicado: (2021)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2022)

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
por: Scardocci, A, et al.
Publicado: (2006)

Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy
por: Hohaus, Stefan, et al.
Publicado: (2017)

Healthy Organs Uptake on Baseline (18)F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's Lymphoma
por: Morland, David, et al.
Publicado: (2022)

Burkitt Lymphoma as Fourth Neoplasia in a Patient Affected by Cowden Syndrome with a Novel PTEN Germline Pathogenic Variant
por: Galli, Eugenio, et al.
Publicado: (2020)

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)

Mantle Cell Lymphoma Relapsing at the Lymphedematous Arm
por: Massini, Giuseppina, et al.
Publicado: (2013)

TOF and TARC
Publicado: (2000)

New Treatments for Myelodysplastic Syndromes
por: D’Alò, Francesco, et al.
Publicado: (2010)

Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2020)

Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2021)

Memorandum: Completion of the TARC experiment
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1997)

Combined Modality Treatment Including Methotrexate-Based Chemotherapy For Primary CENTRAL Nervous System Lymphoma: A Single Institution Experience
por: Hohaus, Stefan, et al.
Publicado: (2009)

Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience
por: Bellisario, Flaminia, et al.
Publicado: (2023)

Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome
por: Torti, Lorenza, et al.
Publicado: (2012)

Members of the TARC Collaboration pictured with their apparatus
Publicado: (1997)

The TARC Experiment at CERN: Modern Alchemy
por: Revol, Jean-Pierre
Publicado: (2017)

Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2022)

Thymus and activation‐regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022)

Similarities and Differences Between Therapy-Related and Elderly Acute Myeloid Leukemia
por: D’Alò, Francesco, et al.
Publicado: (2011)

P034: Correlation between MTV, TLG and Serum TARC Concentration in Classical Hodgkin Lymphoma during First-Line Treatment
por: Romano, Ilaria, et al.
Publicado: (2022)

T027: High serum levels of Thymus and Activation Related Chemokine (TARC) precede Hodgkin lymphoma diagnosis by several years
por: Diepstra, Arjan, et al.
Publicado: (2022)

Analytical Performance of a Novel Latex Turbidimetric Immunoassay, “Nanopia TARC”, for TARC/CCL17 Measurement: A Retrospective Observational Study
por: Yamashita, Keita, et al.
Publicado: (2023)

Determination of the impurity content of the lead assembly for the TARC experiment
por: Embid, M, et al.
Publicado: (1997)

Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter
por: Liddiard, Kate, et al.
Publicado: (2006)

Outcome of therapy-related myeloid neoplasms treated with azacitidine
por: Fianchi, Luana, et al.
Publicado: (2012)

Determination of the beam geometry in the fast extraction mode for the TARC experiment
por: Embid, M, et al.
Publicado: (1997)

Determination of the beam characteristics in the slow extraction mode in the TARC experiment
por: Abánades, A, et al.
Publicado: (1997)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Update on geometric details of the lead assembly and of the experimental area for the TARC experiment
por: Revol, Jean-Pierre
Publicado: (1996)

CCL17/TARC and CCR4 expression in Merkel cell carcinoma
por: Rasheed, Kashif, et al.
Publicado: (2018)

Validation of Neutrons in Geant4 Using TARC Data - production, interaction and transportation
por: Howard, A
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_edf7ar4vommo87h9ttfs5t682u